Abbott Laboratories (ABT 0.01%) is a diversified health care company that gives investors a great deal of stability. Between testing, nutritional products, pharmaceuticals, and medical devices, the ...

Abbott Laboratories is a diversified healthcare supplier with a focus on medical devices, nutrition, diagnostics, and pharmaceuticals. The company experienced a surge in share price due to COVID-19 ...

CHICAGO (WLS) -- A new COVID19 test that provides results in five minutes is set to roll out soon as Illinois-based Abbott Labs expected to deliver 50,000 tests per-day. President Donald Trump did a ...

Abbott is the name behind many well-known products.

Abbott Laboratories reported strong Q4 2023 earnings, with year-over-year growth in EPS and revenue. The company's 2024 guidance projects further growth and improved ...

A new automation system from Abbott, designed to improve workflows in clinical lab settings, has been granted FDA approval. The system, GLP systems Track, uses a self-propelled carrier system that ...

Health Canada has granted approval for Abbott’s i-STAT TBI test cartridge, enabling clinicians to evaluate suspected concussions more effectively. The authorisation allows for the use of the test ...

Sales at Abbott Laboratories' diagnostics unit dropped in the second quarter as demand for COVID-19 tests slumped. The company beat profit and sales estimates on strong sales of its medical devices.

On Wednesday, Abbott Laboratories (NYSE:ABT) reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus of $11.01 billion. Organic sales growth for the underlying ...

A major wrongful death lawsuit has been filed alleging defects in Abbott Laboratories' (NYSE:ABT) FreeStyle Libre 3 and Libre 3 Plus glucose monitoring systems. The claim links the products to seven ...